drugset / Trial / NCT00190606

Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary Incontinence

NCT00190606

Phase 2 Completed 200 enrolled Eli Lilly and Company Boehringer Ingelheim · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The study is a comparison of the efficacy and safety of duloxetine and pelvic floor muscle training with that of placebo in patients with moderate to severe stress urinary incontinence

Timeline

Start
2002-01
Primary completion
Completion
2006-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule